Press release
Interstitial Lung Disease Market Report 2024: Strategies And Recent Developments | Roche Laboratories Inc., Merck & Co. Inc., Bayer AG, Novartis Pharmaceuticals Corporation
Interstitial Lung Disease Market Size
The Business Research Company offers in-depth market insights through Interstitial Lung Disease Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The interstitial lung disease market size has grown strongly in recent years. It will grow from $1.83 billion in 2023 to $1.97 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to awareness and diagnosis improvement, immune system modulation therapies, respiratory rehabilitation programs, multidisciplinary care teams.
The interstitial lung disease market size is expected to see strong growth in the next few years. It will grow to $2.62 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to precision medicine, novel drug development, regenerative medicine, telehealth and remote monitoring. Major trends in the forecast period include advancements in imaging technology, ai in imaging, fibrosis subtype differentiation, supportive care services.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13019&type=smp
Market Segmentation:
The main types of drugs used for interstitial lung disease are oral corticosteroids, immune-suppressing, anti-fibrotic medication and others. Interstitial pneumonia, also known as non-infectious interstitial pneumonia, is a type of interstitial lung disease (ILD) that affects the interstitium, which is the tissue that surrounds and supports the air sacs (alveoli) in the lungs. They are indicated for the treatment of interstitial pneumonia, idiopathic pulmonary fibrosis, nonspecific interstitial pneumonitis, hypersensitivity pneumonitis, cryptogenic organizing pneumonia (COP), sarcoidosis and acute interstitial pneumonitis for adults and children. It is distributed by various channels such as hospital pharmacies, retail pharmacies and online pharmacies.
Major Driver - Role Of Allergic Conditions In Driving Growth Of The Interstitial Lung Disease Market
The growing prevalence of allergic conditions is expected to propel the growth of the interstitial lung disease market going forward. An allergic condition is when the immune system overreacts to an allergen, often known as a harmless substance. Allergic reactions might result in interstitial lung disease (ILD), specifically hypersensitivity pneumonitis, which causes an allergic reaction in the body causes hypersensitivity pneumonitis. For instance, in January 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency for public health, over one-third of American adults and more than one-fourth of American children had a seasonal allergy, eczema, or food allergy in 2021. Further, anaphylaxis (a severe allergic reaction to food) is estimated to cause 90,000 emergency room visits in the United States each year. Therefore, the growing prevalence of allergic conditions is driving the growth of the interstitial lung disease market.
Competitive Landscape:
Major players in the interstitial lung disease market are Roche Laboratories Inc., Merck & Co. Inc., Bayer AG, Novartis Pharmaceuticals Corporation, The Bristol-Myers Squibb Company, Amgen Inc., Boehringer Ingelheim, Siemens Healthineers, Koninklijke Philips N.V., Teva Pharmaceuticals USA Inc., AstraZeneca PLC, Horizon Pharma USA Inc., Genentech Inc., Amneal Pharmaceuticals LLC, Fujirebio Diagnostics Inc., Insmed Inc., VIDA Diagnostics Inc., EmphyCorp Inc., Verseau Therapeutics, Regend Therapeutics Co., LTT Bio-Pharma Co. Ltd., Galecto Biotech, Pulmatrix Inc., PureTech Health PLC, Pneuma Respiratory Inc., Bellerophon Therapeutics Inc., MediciNova Inc., Altavant Sciences Inc., Verona Pharma plc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/interstitial-lung-disease-global-market-report
Top Trend - Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment
Major Companies operating in the interstitial lung disease market are focusing on developing innovative drugs to treat their customers and sustain their position in the market. The development of new drugs can improve treatment outcomes for patients with lung-related diseases. For instance, in April 2021, United Therapeutics, a US-based biotechnology company, launched Tyvaso, a medication for treating patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability. Tyvaso is a treatment for patients with Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD). It is a sterile version of the prostacyclin-mimicking drug treprostinil that is meant to be inhaled orally utilizing the Tyvaso inhalation system.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Interstitial Lung Disease Market Characteristics
3. Interstitial Lung Disease Market Trends And Strategies
4. Interstitial Lung Disease Market - Macro Economic Scenario
5. Interstitial Lung Disease Market Size And Growth
…..
27. Interstitial Lung Disease Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Interstitial Lung Disease Market Report 2024: Strategies And Recent Developments | Roche Laboratories Inc., Merck & Co. Inc., Bayer AG, Novartis Pharmaceuticals Corporation here
News-ID: 3404505 • Views: …
More Releases from The Business Research Company
Global Wind Tunnel Market to Reach $3.53 Billion by 2029, Growing at 5% CAGR
What market dynamics are playing a key role in accelerating the growth of the wind tunnel market?
The escalating need for UAVs (unmanned aerial vehicles), which are aircraft that do not require a human pilot, flight personnel, or passengers, is contributing to the expansion of the wind tunnel market. The progress in automation across various industries has boosted the demand for UAVs. Wind tunnels are leveraged by engineers to refine the…
Global Visible And UV Laser Diode Market Projected to Surpass $4.68 Billion by 2 …
What industry-specific factors are fueling the growth of the visible and uv laser diode market?
The visible and UV laser diode market is experiencing high demand due to increasing adoption in the automotive sector. The term ""automotive sector"" pertains to the industry that includes all aspects of automotive creation, distribution, sales, and maintenance. Visible and UV laser diodes are primarily used in the automotive industry for distance measurement in driver assistance…
Global Valve Positioner Market Projected to Surpass $2.61 Billion by 2029 with 6 …
How Are the key drivers contributing to the expansion of the valve positioner market?
The expansion of various industrial sectors is anticipated to propel the valve positioner market's growth. This upsurge is primarily attributed to factors like economic advancement, immigration, government backing, among others. A valve positioner, an apparatus linked to the valve stem, interacts with the process controller and actuator to ascertain the valve's exact location. They are widely employed…
Leading Growth Driver in the Transfer Switch Market in 2025: Transfer Switch Mar …
Which drivers are expected to have the greatest impact on the over the transfer switch market's growth?
The transfer switch market is poised for growth, driven by the increasing need for a consistent and uninterrupted power supply. The power supply is an element that provides power to a minimum of one electrical load. Typically, it changes one form of electrical power to another, but it also has the potential to convert…
More Releases for Interstitial
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
Interstitial Lung Disease Therapeutics - Pipeline Analysis 2018
Interstitial lung disease is a type of inflammatory disease that affects and thickens the interstitium of the lungs.
Download the sample report @ https://www.pharmaproff.com/request-sample/1126
The interstitium is a lace like network of the tissue that provide support to the air sacs and the capillaries in the interstitium which allows the gas exchange between the blood and alveolar tissues.
Get the detailed analysis @ https://www.pharmaproff.com/report/interstitial-lung-disease-therapeutics-pipeline-analysis
Some of the types of the condition include…
Interstitial Cystitis-Pipeline Review H2 2018
Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome)-Pipeline Review, H2 2018
Summary
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome)-Pipeline Review, H2 2018, provides an overview of the Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System) pipeline landscape.
Interstitial cystitis also called painful bladder syndrome is a chronic condition in which person experience bladder pressure, bladder pain and sometimes pelvic pain, ranging from mild discomfort…
Interstitial Cystitis Therapeutics Pipeline Analysis, Patent, Designation & Coll …
Interstitial cystitis, also known as painful bladder syndrome is a condition that causes painful urinary symptoms that differs from person to person. Mild discomfort, tenderness in the pelvic area, bladder pain and increased frequency to urinate, are some of the observed symptoms in the patients suffering from interstitial cystitis. Irritable bowel syndrome, chronic fatigue syndrome, fibromyalgia and autoimmune diseases are also observed to be associated with interstitial cystitis in the…
Interstitial Cystitis-Pipeline Review H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Interstitial Cystitis (Painful Bladder Syndrome)-Pipeline Review, H2 2017, provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome) (Genito Urinary System And Sex Hormones) pipeline landscape.
Interstitial cystitis also called painful bladder syndrome is a chronic condition in which person experience bladder pressure, bladder pain and sometimes pelvic pain, ranging from mild discomfort to severe pain. Symptoms include decreased bladder capacity,…
Interstitial Cystitis Market Research Report | Analysis & Trends 2025
Interstitial cystitis (IC), also known as painful bladder syndrome, is a chronic bladder issue often associated with bladder pressure and pain, with occasional pain in either the lower abdomen, pelvic, or lower back. The patient could experience pain raging from mild to severe. The pelvic nerve signal to the brain gets mixed up in an individual suffering from interstitial cystitis. Consequently, an urgency to urinate, often in a small volume,…
